Jianqing Lin
Thomas Jefferson University · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jianqing Lin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:09 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT01848067 · Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate CancerSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer · principal investigator
- Ph2NCT01313559 · Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate CancerSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · terminated · Castrate Resistant Prostate Cancer, Chemotherapy Naive Prostate Cancer, Prostate Cancer · principal investigator
- Ph2NCT01162135 · Digoxin for Recurrent Prostate CancerSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:09 UTC. The ranking covers the 200 most relevant of 1294 PubMed records, and a shared surname and initials can bring in a namesake. All 1294 on PubMed
- Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.N Engl J Med · 2017600 citationsRCR 27.9
- 578 citationsRCR 30.3
- 493 citationsRCR 19.9
- Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.J Clin Oncol · 2023466 citationsRCR 43.5
- Calorie Restriction with or without Time-Restricted Eating in Weight Loss.N Engl J Med · 2022412 citationsRCR 33.5
- Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA.N Engl J Med · 2021329 citationsRCR 21.1
- 304 citationsRCR 21.4
- Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.Blood · 2019277 citationsRCR 9.0
- 251 citationsRCR 28.5
- Assessment of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomized Controlled Trial.Ann Surg · 2021221 citationsRCR 18.1